Author(s):
G. Ravi, P. Subhash Chandra Bose, Valluru Ravi, Damineni Sarita, P. Srikanth Reddy, Sandeep Kanna
Email(s):
penjurisubhash@gmail.com
DOI:
10.5958/0974-360X.2020.00682.4
Address:
G. Ravi1, P. Subhash Chandra Bose1, Valluru Ravi, Damineni Sarita2, P. Srikanth Reddy1, Sandeep Kanna1
1Department of Pharmaceutics, MNR College of Pharmacy, Sangareddy - 502294, Telangana State, India.
2Department of Pharmaceutics, Sultan-ul-Uloom College of Pharmacy, Hyderabad-500034, TS, India.
*Corresponding Author
Published In:
Volume - 13,
Issue - 8,
Year - 2020
ABSTRACT:
The aim of the present study was to develop controlled release formulation of Oxybutynin to maintain constant therapeutic levels of the drug for over 12 hrs. Karaya gum, Acacia and Tragacanth were employed as polymers. All the formulations were passed various physicochemical evaluation parameters and they were found to be within limits. From the dissolution studies it was evident that the formulation (F4) showed better and desired drug release pattern i.e., 98.14 % in 12 hours. It contains the Acacia polymer. It followed Zero order release kinetics mechanism.
Cite this article:
G. Ravi, P. Subhash Chandra Bose, Valluru Ravi, Damineni Sarita, P. Srikanth Reddy, Sandeep Kanna. Development and Evaluation of oral controlled release tablets of oxybutynin using various polymers. Research J. Pharm. and Tech. 2020; 13(8):3854-3860. doi: 10.5958/0974-360X.2020.00682.4
Cite(Electronic):
G. Ravi, P. Subhash Chandra Bose, Valluru Ravi, Damineni Sarita, P. Srikanth Reddy, Sandeep Kanna. Development and Evaluation of oral controlled release tablets of oxybutynin using various polymers. Research J. Pharm. and Tech. 2020; 13(8):3854-3860. doi: 10.5958/0974-360X.2020.00682.4 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2020-13-8-55
REFERENCES:
1. Sathish U, Shravani B, Raghavendra Rao NG, Srikanth Reddy M, Sanjeev NB. Overview on controlled release dosage form. Int J Pharm Sci. 2013;3(4):258-269.
2. Ali N, Shaista R, Pryia P, Kofi A. The Role of oral controlled release matrix tablets in drug delivery systems. Bioimpacts. 2012;2(4):175–187.
3. Mamidala R, Ramana V, Lingam M, Gannu R, Rao MY. Review article factors influencing the design and performance of oral sustained/controlled release dosage form. Int. J. Pharm. Sci. Nanotech. 2009;2:583.
4. Patel N, Chaudhary A, Soni T, Sambyal M, Jain H, Upadhyay U. Controlled drug delivery system: A Review. Indo American J Pharm Sci. 2016;3 (3):227-233.
5. Kumar S, Shashikant, Bharat P. Sustained release drug delivery system: A Review. Int. J. Inst. Pharm. Life Sci. 2012;2(3):356-376.
6. Kar RK, Mohapatra S, Barik BB. Design and characterization of controlled release matrix tablets of Zidovudine. Asian J Pharm Cli Res. 2009;2:54.
7. Cristina M, Aranzaz Z, Jose ML. Critical factors in the release of drugs from sustained release hydrophilic matrices. J Control Rel. 2011;154:2-19.
8. Chugh I, Seth N, Rana AC and Gupta S. Oral sustained release drug delivery system: an overview. Int Res J Pharm. 2012;3(5):57-62.
9. Bhargava A, Rathore RPS, Tanwar YS, Gupta S, Bhaduka G. Oral sustained release dosage form: an opportunity to prolong the release of drug. Int J Adv Res Pharm Bio Sci. 2013;3(1):7-14.
10. Thakor RS, Majmudar FD, Patel JK, Rajpit JC. Review: Osmotic drug delivery systems current scenario. J Pharm Res. 2010;3(4):771- 775.
11. Modi K, Modi M, Mishra D, Panchal M, Sorathiya U, Shelat P. Oral controlled release drug delivery system: an overview. Int Res J Pharm. 2013;4(3):70-76.
12. Ratnaparkhi MP, Gupta JP. Sustained release oral drug delivery system - an overview. Int J Pharm Res Rev, 2013;2(3):11-21.
13. Shah N, Patel N, Patel KR, Patel D. A review on osmotically controlled oral drug delivery systems. J Pharm Sci Bio Res. 2012;2(5):230-237.
14. Thombre NA, Aher AS, Wadkar AV, Kshirsagar SJ. A review on sustained release oral drug delivery system. Int J Pharm Res Sch, 2015;4(2):361-371.
15. Dusane AR, Gaikwad PD, Bankar VH, Pawar SP. A review on: sustained released technology. Int J Res Ayu Pharm. 2011;2(6):1701-1708.
16. Shamma SP, Haranath C, Reddy CPS, Sowmya C. An overview on SR tablet and its technology. Int J Pharm Drug Ana. 2014;2(9):740-747.
17. Tulshi C, Natasha, Vipin S, Rubi. Formulation and Evaluation of Controlled Release Floating Tablets Of Cefixime Using Hydrophilic Polymers. Int. Res. J. Pharm. 2019,10(1).
18. Ram Prasad B, Bhikshapathi DVRN. Design and in vivo Evaluation of Controlled Release Gliclazide Trilayer Matrix Tablets in the Management of Diabetes Mellitus. Int J Pharm Sci Drug Res. 2018;10(5):410-417.
19. Meena S, Manivannan R, Santhosh KG. Formulation and Evaluation of Telmisartan with Hydrochlorothiazide Conventional Release Tablets. Int J Pharm Pharm Res. 2018;12(4):50-59.